Preferred Label : olutasidenib;

UNII : 0T4IMT8S5Z;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/olutasidenib
2023
false
false
false
France
French
olutasidenib
administration, oral
drug information

---
https://www.has-sante.fr/jcms/p_3468410/fr/olutasidenib-pharma-blue-leucemie-aigue-myeloide
2023
false
false
false
France
treatment outcome
adult
Recurrent Adult Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
IDH1 protein, human
mutation
leukemia, myeloid, acute
evaluation of the transparency committee
leukemia, myeloid, acute
olutasidenib

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.